Preoperative radionuclide lymphangiography and sentinel node localization with radionuclide techniques. Advantages and ambiguous aspects

Hellenic Journal of Nuclear Medicine

Volumn 7, Issue 1, 2004, Pages 5-13

  Koukouraki, Sofia ^a   Sanidas, Helias ^b   Karkabitsas, Nikolaos ^b  

^a UNIVERSITY HOSPITAL OF IRAKLION   (Greece)

^b NONE

Author keywords

Breast cancer; Lymphoscintigraphy; Melanoma; Sentinel node biopsy

Indexed keywords

RADIOISOTOPE; TRACER;

AXILLARY LYMPH NODE; BREAST CANCER; CANCER PATIENT; DIAGNOSTIC VALUE; EARLY CANCER; HUMAN; INJECTION; INTRAOPERATIVE PERIOD; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHANGIOGRAPHY; LYMPHOSCINTIGRAPHY; MELANOMA; OCCULT CANCER; PREOPERATIVE EVALUATION; PROGNOSIS; RETROSPECTIVE STUDY; REVIEW; SENTINEL LYMPH NODE BIOPSY;

EID: 2542474203     PISSN: 00258024     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (89)

1. Sappey MPC. Anatomie, Physiologie, Pathologie des Vaisseaux Lymphatiques Concideres chez l homme et les Vertebres. Paris, A Delahaye et E Lacrosner 1874-1875.
2. Morton DL, Wend D, Wong JH et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992, 127:392.
3. Krag DN. History of the sentinel node concept and techniques. Curr Prob Surg 1998; 35(11): 956-959.
4. Sayegh E, Brooks T, Sacher E, et al. Lymphangiography of the retroperitoneal lymph nodes though the inguinal route. J Urol 1966; 95: 13-20.
5. Morton DL, Chan AD. The concept of sentinel node localization: How it started. Semin Nucl Med 2000; 30(1): 4-10.
6. De Cicco C, Cremonesi M, Luini A, et al. Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer. J Nucl Med 1998; 39(12): 2080-2084.
7. Ell P, Keshtgar MRS. The sentinel node and lymphoscintigraphy in breast cancer. Nucl Med Commun 1999; 20: 303-316.
8. Hickernell TS, Barber HB, Barret HH, et al. Dual detector probes for surgical tumor staging. J Nucl Med 1988; 29(6): 1101-1106.
9. Barber HB, Barret HH, Woolfenden JM, et al. Comparison of in vivo scintillation probes and gamma cameras for detection of small deep tumors. Phys Med Biol 1989; 34: 727-739.
10. 2 surgical probes physical characterization. Med Phys 1991; 18: 373-381.
11. Brittan AJ. A method to evaluate intraoperative gamma probes for sentinel lymph node localization. Eur J Nucl Med 1999; 26: 76-83.
12. Abraham J, Wilhelm G, Mijnhout S, et al. Radiopharmaceuticals in sentinel lymph node detection. Eur J Nucl Med 1999; 26 Suppl 36-42.
13. Class EC, Essner R, Morton D. Kinetics of three lymphoscintigraphic agents in patients with cutaneous melanoma. J Nucl Med 1998; 39(7): 1185-1190.
14. Bergquist L, Strand SE, Persson BR. Particle sizing and biokinetics of interstitial lymphoscintigraphic agents. Semin Nucl Med 1983; 13(1): 9-19.
15. De Cicco C, Chinol M, Paganelli G, et al. Intraoperative localization of the sentinel node in breast cancer. Technical aspects of lymphoscintigraphic methods. Sem Surg Oncol 1998; 15: 268-271.
16. Nathanson DS, Wachna LD, Gilman D, et al. Pathways of lymhatic drainage from the breast. Ann Surg Oncol 2001, 8(10): 837-843
17. Rutgers E, Jansen L, Nieweg O, et al. Technique of sentinel node biopsy in breast cancer. Eur J Surg Oncol 1998; 24: 316-330.
18. Lienehan DC, Hill ADK, Akhurst T, et al. Intradermal radiocolloid and intraparenchymal blue dye injection optimize sentinel node identification in breast cancer patients. Ann Surg Oncol, 6(5): 450-454.
19. Keshtgar MRS, Waddington WA, Lakham SR, et al. The sentinel node in surgical oncology. Springer - Verlag Berlin, Heidemberg New York, 1999.
20. Rodier JF, Janser JC. Surgical technical details improving sentinel node identification in breast cancer. Oncol Rep 1997; 4: 281-283.
21. Sandrucci S, Mussa A. Sentinel lymph node biopsy and axillary staging of T1-T2 N0 breast cancer: a multicenter study. Sem Surg Oncol 1998; 15: 278-283.
22. Cox C, Pendas S, Cox J, et al. Guidelines for the sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 1998; 5:645-653.
23. Albertini J, Lyman G, Cox C, et al. Lymphatic mapping and sentinel node biopsy in patients with breast cancer. JAMA 1996; 276:1818-1822.
24. Cavanese G, Gipponi M, Cattirich A, et al. Sentinel lymph node mapping opens a new perspective in the surgical management of early stage of breast cancer: A combined approach with vital blue dye lymphatic mapping and radioguided surgery. Sem Surg Oncol 1998; 15: 272-278.
25. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer. N Engl J Med 1998; 339: 941-946.
26. Kern KA, Rosenberg R. Preoperative lymphoscintigraphy during lymphatic mapping for breast cancer: improved sentinel node imaging using subareolar injection of technetium 99m sulfur colloid. J Am Coll Surg 2000; 191(5): 479-489.
27. Shimazu K, Tamaki Y, Taguchi T, et al. Comparison between perialeolar and peritumoral injection of radiotracer for sentinel lymph node biopsy in patients with breast cancer. Surgery March 2002; 131(3): 277-286.
28. Tuttle Todd M, Colbert M, Christensen R, et al. Subareolar injection of 99mTc facilitates sentinel lymphnode identification. Ann Surg Oncol 2002; 9(1): 77-81.
29. Pelosi E, Baiocco C, Ala A, et al. Lymphatic mapping in early stage breast cancer; comparison between perialeolar and subdermal injection. Nucl Med Commun 2003; 24: 519-523.
30. Wilhelm AJ, Mijnhout GS, Franssen EJF. Radiopharmaceuticals in sentinel lymph node detection: an overview. Eur J Nucl Med 1999; 26: 36-42.
31. Valdes Olmos RA, Hoefnagel CA, Nieweg OE, et al Lymphoscintigraphy in Oncology: a rediscovered challenge. Eur J Nucl Med 1999; 26: 2-10.
32. Ollila D, Brennan M, Giuliano A. The role of intraoperative lymphatic mapping and sentinel lymphadenectomy in the management of patients with breast cancer. Advances in Surg 1999; 32: 349-364.
33. Alex JC, Krag DN. Gamma probe guided localization of lymph nodes. Surg Oncol 1993; 2: 137.
34. Gulec SA, Moffat FL, Carrol RG, et al. Gamma probe guided sentinel node biopsy in breast cancer. Quart J Nucl Med 1997; 41: 251-261.
35. Snider H, Dowlatshahi K, Fan M, et al. Sentinel node biopsy in the staging of breast cancer. Am J Surg 1998; 176: 305-310.
36. Pijpers R, Meijer S, Hoekstra O, et al. Impact of lymphoscintigraphy on sentinel node identification with Technetium 99m colloidal albumin in breast cancer. J Nucl Med 1997; 38: 366-368.
37. Nieweg OE, Jansen L, Kroon BBR. Technique of lymphatic mapping and sentinel node biopsy for melanoma. Eur J Surg Oncol 1998; 24: 520-524.
38. Beechey-Newman N. Sentinel node biopsy: a revolution in the surgical management of breast cancer? Cancer Treatm Rev 1998; 24: 185-203.
39. Borgstein P, Pijpers R, Comans E, et al. Sentinel lymph node biopsy in breast cancer. Guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998; 186: 275-283.
40. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 1997; 349: 864-867.
41. Ent Van der, Kengen RAM, Poll Van der, et al. Sentinel node biopsy in 70 unselected patients with breast cancer: increased feasibility by using 10 mCi radiocolloid in combination with a blue dye tracer. Eur J Surg Oncol 1999; 25: 24.
42. Krausz Y, Ikeda DM, Jadvar H, et al. Non visualization of sentinel lymph node in patients with breast cancer. Nucl Med Commun 2001; 22: 25-32.
43. Chua AC, Lannin DP, Vaneyk JJ, et al. Age and surgeons experience: the only significant factors contributing to sentinel node mapping failure in breast cancer (abstract) Breast Cancer Res Treatm 1999; 57: 27.
44. Birdwell R, Smith K, Betts B, et al. Breast cancer: variables affecting sentinel lymph node visualization at preoperative lymphoscintigraphy. Radiology 2001; 2220(1): 47-53.
45. Borgstein PJ, Pijpers R, Comans EF, et al. Sentinel lymph node biopsy in breast cancer. Guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998; 186: 275-283.
46. Uren RF, Howman Giles RB, Shaw HM, et al. Lymphoscintigraphy in high risk melanoma of the trunk. Predicting draining node groups, defining lymphatic channels and locating the sentinel node. J Nucl Med 1993; 34:1435-1440.
47. Uren RF, Howman Giles RB, Thompson JF, et al. Lymphatic drainage to triangular space lymph nodes in melanoma on the back. J Nucl Med 1996; 37: 964-966.
48. Uren RF, Howman Giles RB, Thompson JF. Lymphatic drainage from the skin of the back to retroperitoneal and paravertebral lymph nodes in melanoma patients. Ann Surg Oncol 1998; 5: 384-387.
49. Thompson JF, Uren RF, Shaw HM, et al. Location of sentinel nodes in patients with cutaneous melanoma: new insights into lymphatic anatomy. J Am Coll Surg 1999; 189: 195-206.
50. Giuliano AE, Kirgan DM, Guenther GM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994; 220: 391-401.
51. Morris K, Stevens J, Pommier R, et al. Usefulness of preoperative lymphoscintigraphy for the identification of sentinel lymph nodes in melanoma. Am J Surg 2001; 181: 423-426.
52. Meyer CM, Lecklitner ML, Logic JR, et al. Technetium 99m sulfur colloid cutaneous lymphoscintigraphy in the management of truncal melanoma. Radiology 1979; 131: 205-209.
53. Springall SJ, Rytina ERC, Millis RR. Incidence and significance of micrometastasis in axillary lymphnodes detected by immunohistochemical techniques. J Pathol 1990; 160:174A.
54. Bostick P, Essner R, Glass E, et al. Comparison of blue dye and probe- assisted intraoperative lymphatic mapping in melanoma to identify sentinel nodes in 100 lymphatic basins. Arch Surg 1999; 134: 43-49.
55. Morris K, Stevens J, Pommier R, et al. Usefulness of preoperative lymphoscintigraphy for the identification of sentinel lymph nodes in melanoma. Am J Surg 2001; 181: 423-426.
56. Ege GN. Lymphoscintigraphy - Techniques and applications in the management of breast carcinoma. Semin Nucl Med 1983; 13(1): 26-34
57. Rossi R, Ferri O. La visualizaziione della catena mammaria internale con 198 Au. Presentazione di una nuova metodica: la limfoscintigrafia. Minerva Med 1966; 57: 1151-1155.
58. Kazem I, Antoniades J, Brady LM, et al. Clinical evaluation of lymph node scanning utilizing colloidal gold 198. Radiology 1968; 90: 905-911.
59. McMasters K, Giuliano A, Ross M, et al. Sentinel lymphnode biopsy for breast cancer not yet the standard of care. N Engl J Med 1998; 339: 990-995.
60. De Cicco C, Cremonesi M, Luini A, et al Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer. J Nucl Med 1998; 39(12): 2080-2084
61. Burak W, Walker M, Yee L, et al. Routine preoperative lymphoscintigraphy is not necessary prior to sentinel node biopsy for breast cancer. Am J Surg 1999; 177: 445-449.
62. Liberman L, Cody HS, Hill ADK, et al. Sentinel lymph node biopsy after percutaneous diagnosis of non palpable breast cancer. Radiology 1999; 211: 835-844.
63. McMasters K, Wong SL, Tuttle TM, et al. Preoperative lymphoscintigraphy for breast cancer does not improve the ability to identify axillary sentinel lymphnodes. Ann Surg 2000; 231(5): 724-729.
64. Kern K, Rosenberg R. Preoperative lymphoscintigraphy during lymphatic mapping for breast cancer: improved sentinel node imaging using subareolar injection of technetium 99msulfur colloid. J Am Coll Surg 2000; 191(5): 479-489.
65. Reintgen D, Giuliano R, Cox CE. Sentinel node biopsy in breast cancer: An overview. Breast J 2000; 6(5): 299-305.
66. Cady B, Chung M. Invited commentary: sentinel node biopsy- comment on techniques. Surgery 2000; 128(1): 13-15.
67. Kapteijn BAE, Nieweg OE, Valdes Olmos, et al. Reproducibility of lymphoscintigraphy for lymphatic mapping in cutaneous melanoma. J Nucl Med 1996; 37: 972-975.
68. Roumen RMH, Valkenburg JGM, Geuskens LM, et al. Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast cancer. Eur J Surg Oncol 1997; 23: 495-502.
69. Gulec SA, Moffat FL, Caroll RG, et al. Gamma probe guided sentinel node biopsy in breast cancer. Quart J Nucl Med 1997; 41: 251-261.
70. Veronesi U, Paganelli G, Viale G, et al. Sentinel lymph node biopsy and axillary dissection in breast cancer. Results in a large series. J Natl Cancer Inst 1999; 91: 368-373.
71. Tanis PJ, Nieweg OE, Valdes Olmos RA, et al. Impact of non axillary sentinel node biopsy on staging and treatment of breast cancer patients. Brit J Surgery 2002; 87: 705-710.
72. Veronesi U, Valagussa P. Inneficacy of internal mammary nodes dissection in breast cancer surgery. Cancer 1981; 47:170-175.
73. Byrd D, Dunwald L, Mankoff D, et al. Internal Mammary lymph node drainage patterns in patients with breast cancer documented by breast lymphoscintigraphy. Annals Surg Oncol 2001; 8(3): 234-240.
74. Nieweg OE, Rutgers EJT, Jansen L, et al. Is lymphatic mapping in breast cancer adequate and safe? World J Surg 2001; 25: 780-788.
75. Krag DN, Meijer SJ, Weaver DL, et al. Minimal access surgery for staging malignant melanoma. Arch Surg 1995; 130: 654-658.
76. Ross MI. Lymphatic mapping and sentinel node biopsy for early stage melanoma: how we do it at the MD Anderson Cancer Center. J Surg Oncol 1997; 66:273-276.
77. Mudun A, Murray DR, Herda SC, et al. Early stage melanoma: lymphoscintigraphy, reproducibility of sentinel node detection and effectiveness of the intraoperative gamma probe. Radiology 1996; 199: 171-175.
78. O'Brien CJ, Uren RF, Thompson JF, et al. Prediction of potential metastatic sites in cutaneous head and neck melanoma using lymphoscintigraphy. Am J Surg 1995; 170: 461-466.
79. Reintgen D, Cruse W, Wells K, et al. The orderly progression of melanoma node metastasis. Ann Surg 1994; 220: 759-767.
80. Doting MHE, Jansen L, Nieweg OE, et al. Lymphatic mapping with intralesional tracer administration in breast carcinoma patients. Cancer 2000; 88(11): 2546-2552.
81. Gennari R, Bartholomei M, Testori A, et al. Sentinel node localization in primary melanoma: preoperative dynamic lymphoscintigraphy, intraoperative gamma probe and vital dye guidance. Surgery 2000; 127(1): 19-25.
82. Derossis AM, Fey J, Yeung H, et al. A trend analysis of the relative value of blue dye and isotope localization in 2000 consecutive of sentinel node biopsy for breast cancer. J Am Coll Surg 2001; 193(5): 473-478.
83. Nogushi S, Aihara T, Motomura K, et al. Detection of breast cancer micrometastasis in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Am J Pathol 1996; 2: 649-656.
84. Springall SJ, Rytina ERC, Millis RR. Incidence and significance of micrometastasis in axillary lymph nodes detected by immunohistochemical techniques. J Pathol 1990; 160: 174.
85. Valdes Olmos RA, Jansen L, Hoefnagel OE, et al. Evaluation of mammary lymphoscintigraphy by single intratumoral injection for sentinel node identification. J Nucl Med 2000; 41: 1500-1506.
86. Valdes Olmos RA, Tanis PJ, Hoefnagel OE, et al. Improved sentinel node visualization in breast cancer by optimizing the colloid particle concentration and tracer dosage. Nucl Med Commun 2001; 22: 579-586.
87. Solorzano CC, Ross MI, Delpassand E, et al. Utility of breast sentinel node biopsy using day before surgery injection of high dose 99mTc labeled sulfur colloid. Ann Surg Oncol 2001; 8(10): 821-827.
88. Nogushi M. Sentinel lymph node biopsy and breast cancer. Brit J Surg 2002; 89: 21-34.
89. Bronskill MJ. Radiation dose estimates for interstitial radiocolloid lymphoscintigraphy. Sem Nucl Med 1993; 8: 20-25.